High Throughput Process Development Market to Reflect Impressive Growth Rate in Biotechnology Industry

Growth in the ****** market is mainly driven by the increasing R&D spending, technological advancements in process development, growth in the biopharmaceutical industry, and growing pressure to lower the cost of manufacturing. However, factors such as the high cost of technology and equipment in this market and lack of adequate infrastructural facilities are restraining the growth of this market to a certain extent.

The ****** high throughput process development market is expected to reach USD 415.5 Million in 2021 from USD 162.9 Million in 2015, at a CAGR of 14.4% during the forecast period.

Based on technology, the market is categorized into chromatography, ultraviolet-visible spectroscopy, and others (ELISA, chip electrophoresis, SPR, and qPCR). The chromatography segment accounted for the largest share of the ****** market in 2016. The chromatography segment is further divided into ion exchange chromatography (IEC), affinity chromatography (AC), multimodal chromatography (MC), and others (hydrophobic charge induction chromatography (HCIC) and size exclusion chromatography). The affinity chromatography segment accounted for the largest share of the chromatography high throughput process development in 2016. Owing to the advantages of affinity chromatography over other chromatography such as high selectivity, high flow rate and its capacity for extensive removal of process-related impurities such as host cell proteins, DNA, and Cell Culture media component are driving the growth of the market.

Based on product and service, the market is categorized into consumables, instruments, services, and software. The consumables segment accounted for the largest share of the ****** high throughput process development market in 2016. The availability of a wide range of reagents and continuous product developments and innovations are expected to drive the HTPD consumables market.

Factors such as the high cost of technology and equipment in this market and the lack of adequate infrastructural facilities are restraining the growth of this market to a certain extent.

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=10249359

Geographical Region Covered

Geographically, North America (comprising the US and Canada) accounted for the largest share of the ****** market in 2016. Factors such as increasing R&D spending by pharmaceutical and biopharmaceutical companies, growing demand for technical tools for improving the production quality of biological materials, collective pressure towards lowering the cost of manufacturing biological materials, rising demand for reducing product development timelines, and the presence of major players in this region are driving the growth of the North American market.

Leading Companies

Major players operating in the high throughput process development market include Danaher (US), GE Healthcare (US), Agilent Technologies (US), Merck Millipore (Germany), and Thermo Fisher Scientific (US).